Frontier Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$507K Buy
5,807
+64
+1% +$5.52K 0.03% 154
2020
Q1
$474K Sell
5,743
-353
-6% -$31.5K 0.04% 141
2019
Q4
$577K Buy
6,096
+970
+19% +$87K 0.03% 162
2019
Q3
$445K Buy
5,126
+675
+15% +$60.6K 0.03% 163
2019
Q2
$406K Sell
4,451
-808
-15% -$68.4K 0.03% 160
2019
Q1
$453K Buy
5,259
+638
+14% +$51.2K 0.03% 175
2018
Q4
$355K Buy
4,621
+16
+0.3% +$1.25K 0.03% 179
2018
Q3
$355K Buy
4,605
+427
+10% +$31.6K 0.03% 192
2018
Q2
$283K Sell
4,178
-9
-0.2% -$621 0.02% 198
2018
Q1
$303K Hold
4,187
0.03% 174
2017
Q4
$315K Sell
4,187
-1,035
-20% -$78.1K 0.03% 177
2017
Q3
$402K Buy
5,222
+1,281
+33% +$96.7K 0.03% 167
2017
Q2
$295K Buy
3,941
+63
+2% +$4.46K 0.03% 182
2017
Q1
$240K Buy
+3,878
New +$258K 0.02% 172
2016
Q4
Sell
-2,839
Closed -$2.01M 204
2016
Q3
$2.01M Buy
+2,839
New +$207K 0.02% 184
2016
Q1
Sell
-2,643
Closed -$204K 181
2015
Q4
$204K Hold
2,643
0.03% 150
2015
Q3
$218K Buy
2,643
+86
+3% +$7.65K 0.04% 151
2015
Q2
$225K Buy
2,557
+90
+4% +$8.26K 0.03% 162
2015
Q1
$225K Hold
2,467
0.03% 163
2014
Q4
$205K Buy
+2,467
New +$204K 0.03% 162

Other funds holding NVS

Frontier Investment Management's NVS Position: Q2 2020 in Review

Frontier Investment Management increased its Novartis (NVS) stake by 1.1% in Q2 2020, buying an estimated $5.52K and bringing the position to 5,807 shares worth $507K. The position accounts for 0.03% of the portfolio, ranked #154.

Frontier Investment Management first reported a position in NVS in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.01M in Q3 2016. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • Frontier Investment Management held 5,807 shares of Novartis worth $507K as of Q2 2020.
  • Frontier Investment Management bought 64 Novartis shares in Q2 2020, an estimated $5.52K.
  • Novartis made up 0.03% of Frontier Investment Management's portfolio in Q2 2020, its #154 holding.
  • Frontier Investment Management first reported a position in Novartis in Q4 2014 and has held it in 20 quarters since.
  • Frontier Investment Management's Novartis position peaked at $2.01M in Q3 2016.
  • 1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.